Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

50
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
50
Relative Risk01:12

Relative Risk

104
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
104
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

115
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
115
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

74
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
74
Regression Toward the Mean01:52

Regression Toward the Mean

6.3K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.3K
Hazard Rate01:11

Hazard Rate

83
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
83

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of COVID-19 pandemic on admission, management and mortality of pulmonary embolism in cancer patients.

International journal of cardiology. Cardiovascular risk and prevention·2026
Same author

Pelvic Lead Apron Shielding During Transradial Approach: Simple and Affordable Method to Reduce Scatter Radiation.

JACC. Cardiovascular interventions·2026
Same author

Frailty Impact on Periprocedural Outcomes of Atrial Fibrillation Ablation.

Journal of clinical medicine·2026
Same author

Mitral regurgitation and in-hospital outcomes of percutaneous left atrial appendage closure.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2025
Same author

Anticoagulation Strategies for Left Ventricular Thrombus After Myocardial Infarction: A Review.

Journal of clinical medicine·2025
Same author

Impact of cardiovascular-kidney-metabolic syndrome staging on clinical outcomes and management of acute pulmonary embolism: A comprehensive analysis.

International journal of cardiology. Heart & vasculature·2025

Related Experiment Video

Updated: May 23, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

Predicting mortality risk using the PREVENT equation across diverse racial groups.

Ofer Kobo, Martin K Rutter, Shivani Misra

  • 1Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, David Weatherall Building, Keele, Staffordshire ST5 5BG, United Kingdom.

The American Journal of Managed Care
|May 19, 2025
PubMed
Summary

The PREVENT score accurately predicts cardiovascular risk and mortality across diverse racial and ethnic groups. This tool effectively identifies high-risk individuals, improving cardiovascular disease risk assessment for all populations.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Related Experiment Videos

Last Updated: May 23, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Area of Science:

  • Cardiovascular epidemiology
  • Public health
  • Biostatistics

Background:

  • The PREVENT score is a modern cardiovascular risk assessment tool that excludes race, prompting concerns about its equitable performance.
  • Validating risk prediction models across diverse populations is crucial for equitable healthcare.

Purpose of the Study:

  • To validate the PREVENT cardiovascular risk equation across diverse racial and ethnic groups.
  • To assess the association between PREVENT-estimated cardiovascular risk and long-term all-cause and cardiovascular mortality.

Main Methods:

  • An observational cohort study utilized nationally representative data from the National Health and Nutrition Examination Survey (NHANES) linked with mortality data (2009-2018).
  • A cohort of over 177 million US adults was analyzed, stratified by race and ethnicity.
  • Cox proportional hazards models assessed the relationship between baseline cardiovascular risk and mortality.

Main Results:

  • Significant variations in baseline cardiovascular risk were observed across racial and ethnic groups.
  • Higher estimated cardiovascular risk was consistently associated with increased cardiovascular and all-cause mortality rates.
  • Individuals at high risk had a 6-fold higher risk of all-cause mortality and a 9-fold higher risk of cardiovascular mortality compared to low-risk individuals.

Conclusions:

  • The PREVENT score demonstrates validated performance across diverse racial and ethnic populations.
  • The tool effectively predicts cardiovascular risk and mortality irrespective of race or ethnicity.
  • Findings support the use of the PREVENT score for equitable cardiovascular risk assessment.